Absci Announces Proposed Public Offering of Common Stock

VANCOUVER, Wash., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (NASDAQ:ABSI) ("Absci"), a data-first generative AI drug creation company, announced today that it has commenced an underwritten public offering of $75.0 million of shares of its common stock. Absci also intends to grant the underwriters a 30-day option to purchase up to an additional$11.25 million of shares of its common stock. All of the shares in the proposed offering are to be sold by Absci. Absci intends to use the net proceeds from ...